Article

IKZF3 amplification frequently occurs in HER2 positive breast cancer and is a potential therapeutic target

2022-05-31

Abstract excerpt

<title>Abstract</title> <p>Breast cancer is one of the leading causes of cancer death in women, and although treatment outcome has substantially improved in the past decades, advanced or metastatic breast cancers still carry a poor prognosis. Gene amplification is one of the frequent genetic alterations in cancer, and oncogene amplification may be associated with cancer aggressiveness and oncogenicity. Targeting...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e67ed8be-4ba8-5de2-98c0-83ea25e158e0
DOI: 10.21203/rs.3.rs-1648681/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

IKZF3 amplification frequently occurs in HER2 positive breast cancer and is a potential therapeutic targetDOI 10.21203/rs.3.rs-1648681/v1Read

IKZF3 amplification frequently occurs in HER2-positive breast cancer and is a potential therapeutic target.Semantic proximity Read

Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.Semantic proximity Read

<i>ERBB2</i> / <i>HOXB13</i> co-amplification with interstitial deletion of <i>BRCA1</i> defines a unique subset of breast cancersSemantic proximity Read

Diverse ERBB2/ERBB3 Activating Alterations and Coalterations Have Implications for HER2/3-Targeted Therapies across Solid Tumors.Semantic proximity Read

Comparative Analysis of Clinical and Molecular Characteristics in Invasive Ductal Carcinoma of the BreastSemantic proximity Read

Human Epidermal Growth Factor Receptor 2 Alterations and Prognostic Implications in All Subtypes of Breast Cancers.Semantic proximity Read

Molecular Landscape of ERBB2 Alterations in 14,956 Solid Tumors.Semantic proximity Read

ERBB2-amplified lobular breast carcinoma exhibits concomitant CDK12 co-amplification associated with poor prognostic features.Semantic proximity Read

Characteristics of MYC Amplification and Their Association with Clinicopathological and Molecular Factors in Patients with Breast Cancer.Semantic proximity Read

Whole-Genome Landscape of Breast Cancers from India shows Distinct Clinically Actionable SubtypesSemantic proximity Read

Genomic correlations for clinical outcomes in HER2-positive advanced gastric cancers treated using trastuzumab-based therapySemantic proximity Read

Targetable <i>ERBB2</i> mutation status is an independent marker of adverse prognosis in estrogen receptor positive, <i>ERBB2</i> non-amplified primary lobular breast carcinoma: a retrospective <i>in silico</i> analysis of public datasetsSemantic proximity Read